GENIUS GROUP LTD (GNS)

SGXZ34583559 - Common Stock

0.3988  0 (-0.92%)

After market: 0.3881 -0.01 (-2.68%)

Fundamental Rating

1

Overall GNS gets a fundamental rating of 1 out of 10. We evaluated GNS against 65 industry peers in the Diversified Consumer Services industry. GNS has a bad profitability rating. Also its financial health evaluation is rather negative. GNS is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year GNS has reported negative net income.
GNS had a negative operating cash flow in the past year.

1.2 Ratios

GNS's Return On Assets of -60.32% is on the low side compared to the rest of the industry. GNS is outperformed by 90.63% of its industry peers.
Looking at the Return On Equity, with a value of -768.79%, GNS is doing worse than 84.38% of the companies in the same industry.
Industry RankSector Rank
ROA -60.32%
ROE -768.79%
ROIC N/A
ROA(3y)-34.41%
ROA(5y)N/A
ROE(3y)-309.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of GNS (47.49%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of GNS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for GNS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.38%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

GNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GNS has more shares outstanding
The debt/assets ratio for GNS is higher compared to a year ago.

2.2 Solvency

GNS has an Altman-Z score of -1.30. This is a bad value and indicates that GNS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.30, GNS is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
GNS has a Debt/Equity ratio of 2.04. This is a high value indicating a heavy dependency on external financing.
GNS's Debt to Equity ratio of 2.04 is on the low side compared to the rest of the industry. GNS is outperformed by 76.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.04
Debt/FCF N/A
Altman-Z -1.3
ROIC/WACCN/A
WACC8.44%

2.3 Liquidity

A Current Ratio of 1.04 indicates that GNS should not have too much problems paying its short term obligations.
GNS has a Current ratio of 1.04. This is in the lower half of the industry: GNS underperforms 60.94% of its industry peers.
A Quick Ratio of 0.99 indicates that GNS may have some problems paying its short term obligations.
GNS has a worse Quick ratio (0.99) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.99

5

3. Growth

3.1 Past

The earnings per share for GNS have decreased strongly by -810.50% in the last year.
The Revenue has grown by 119.34% in the past year. This is a very strong growth!
GNS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.29% yearly.
EPS 1Y (TTM)-810.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-637.26%
Revenue 1Y (TTM)119.34%
Revenue growth 3Y22.29%
Revenue growth 5YN/A
Revenue growth Q2Q-70.42%

3.2 Future

Based on estimates for the next years, GNS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.82% on average per year.
The Revenue is expected to grow by 4.07% on average over the next years.
EPS Next Y-69.23%
EPS Next 2Y8.6%
EPS Next 3Y12.82%
EPS Next 5YN/A
Revenue Next Year-24.15%
Revenue Next 2Y-7.93%
Revenue Next 3Y4.07%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

GNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GNS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

GNS's earnings are expected to grow with 12.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.6%
EPS Next 3Y12.82%

0

5. Dividend

5.1 Amount

No dividends for GNS!.
Industry RankSector Rank
Dividend Yield N/A

GENIUS GROUP LTD

NYSEARCA:GNS (5/3/2024, 7:04:01 PM)

After market: 0.3881 -0.01 (-2.68%)

0.3988

0 (-0.92%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap74.23M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.32%
ROE -768.79%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 47.49%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 2.04
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.04
Quick Ratio 0.99
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-810.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-69.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)119.34%
Revenue growth 3Y22.29%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y